Page last updated: 2024-10-29

staurosporine aglycone and Cough

staurosporine aglycone has been researched along with Cough in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research Excerpts

ExcerptRelevanceReference
"Cough was assessed visually, acoustically and by analysis of the airflow signal."1.35Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms. ( El-Hashim, AZ; Jaffal, SM, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Hashim, AZ1
Jaffal, SM1

Other Studies

1 other study available for staurosporine aglycone and Cough

ArticleYear
Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms.
    Thorax, 2009, Volume: 64, Issue:9

    Topics: Airway Obstruction; Animals; Carbazoles; Citric Acid; Cough; Diterpenes; Enzyme Inhibitors; Female;

2009